Artal Group S.A. Relay Therapeutics, Inc. Transaction History

Artal Group S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$9.99 - $18.27 $4.6 Million - $8.4 Million	-460,018 Reduced 27.48%	1,213,725 $15.2 Million
Q1 2023 May 12, 2023	BUY	$15.0 - $22.76 $3.29 Million - $4.99 Million	219,027 Added 15.06%	1,673,743 $27.6 Million
Q3 2022 Nov 14, 2022	BUY	$18.07 - $31.37 $13.6 Million - $23.7 Million	754,716 Added 107.82%	1,454,716 $32.5 Million
Q1 2022 May 12, 2022	SELL	$20.26 - $32.36 $1.01 Million - $1.62 Million	-50,000 Reduced 6.67%	700,000 $21 Million
Q4 2021 Feb 11, 2022	BUY	$26.0 - $37.03 $9.1 Million - $13 Million	350,000 Added 87.5%	750,000 $23 Million

Q3 2020 Nov 13, 2020	BUY	$32.81 - $45.1 $13.1 Million - $18 Million	400,000 New	400,000 $17 Million

187

127M

4.2K

1.7K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $779M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.